Repligen Corp. (NASDAQ:RGEN)

About the company

Repligen Corp. provides advanced bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. The firm serves through the following product lines: Chromatography; Filtration; and OEM Products (Proteins). The Chromatography product line includes a number of products used in the downstream purification and quality control of biological drugs. The Filtration products offer a number of advantages to manufacturers of biologic drugs at volumes that span from pilot studies to clinical and commercial-scale production. The OEM products are represented by Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification, and cell culture growth factor products. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

761

CEO

Tony J. Hunt

Exchange

NASDAQ

Website

http://www.repligen.com

$286.00M

Total Revenue

761

Employees

$6B

Market Capitalization

278.40

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$162M

Operating Margin (in %)

Total operating margin

$37M

Net Margin (in %)

Total net margin

$23M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 383533.80 82729.00 6.16 22.35 20.75
Merck & Co., Inc. MRK 199942.72 48081.00 7.51 19.73 21.10
Pfizer Inc. PFE 190383.75 50660.00 2.88 12.05 31.17
Eli Lilly & Co. LLY 155261.34 23087.00 52.69 27.37 23.97
AbbVie, Inc. ABBV 144918.98 34057.00 -23.20 17.28 24.65
Bristol Myers Squibb Co. BMY 111198.52 31006.00 2.70 94.54 3.08
Repligen Corp. RGEN 6389.28 286.00 6.13 278.40 8.11
Reata Pharmaceuticals, Inc. RETA 4824.84 20.00 22.85 -15.52 -150.30
Nektar Therapeutics NKTR 4363.04 137.00 3.41 -9.50 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 4053.40 1.00 37.48 -6.20 None
Allakos, Inc. ALLK 3236.42 None 7.03 -34.60 None
Karuna Therapeutics, Inc. KRTX 2853.24 None 7.45 -70.35 None
ADC Therapeutics SA ADCT 2565.54 2.00 30.26 -22.00 None
OPKO Health, Inc. OPK 2484.72 891.00 1.77 -8.50 -32.92
Turning Point Therapeutics, Inc. TPTX 2259.72 None 6.80 -18.91 None
IGM Biosciences, Inc. IGMS 2237.27 None 9.86 -41.24 None
Apellis Pharmaceuticals, Inc. APLS 2175.36 None 9.61 -5.22 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 1784.50 None 5.80 -28.62 None
Zymeworks, Inc. ZYME 1622.04 26.00 3.37 -9.56 -629.37
Principia Biopharma, Inc. PRNB 1578.64 30.00 5.62 -22.46 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1544.38 None 9.46 -16.76 None
Akcea Therapeutics, Inc. AKCA 1347.82 341.00 2.77 -47.91 -8.59
Tricida, Inc. TCDA 1319.57 None 6.78 -6.25 None
Kiniksa Pharmaceuticals Ltd. KNSA 1279.85 None 6.63 -10.58 None
Arcutis Biotherapeutics, Inc. ARQT 1154.40 None 4.92 -18.46 None
Akero Therapeutics, Inc. AKRO 1135.64 None 9.48 -22.38 None
Odonate Therapeutics, Inc. ODT 1127.52 None 9.24 -10.02 None
Phibro Animal Health Corp. PAHC 1060.26 818.00 5.35 28.73 4.49
Athenex, Inc. ATNX 1014.78 123.00 6.22 -9.43 -87.86
Constellation Pharmaceuticals, Inc. CNST 983.36 None 4.63 -10.60 None
G1 Therapeutics, Inc. GTHX 818.52 1.00 3.54 -6.24 None
Gossamer Bio, Inc. GOSS 809.47 None 3.28 -4.07 None
Phathom Pharmaceuticals, Inc. PHAT 794.00 None 4.40 -2.92 None
Quanterix Corp. QTRX 732.51 60.00 6.46 -16.75 -71.52
Krystal Biotech, Inc. KRYS 731.00 None 4.26 -35.25 None
Applied Therapeutics, Inc. APLT 711.70 14.00 4.60 -14.44 -19.41
Aprea Therapeutics, Inc. APRE 689.64 None 6.10 -20.40 None
Oric Pharmaceuticals, Inc. ORIC 687.96 None -7.47 -22.75 None
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Arcturus Therapeutics Holdings, Inc. ARCT 665.08 19.00 61.64 -23.91 -151.34
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Amneal Pharmaceuticals, Inc. AMRX 617.87 1679.00 4.25 -2.84 -11.85
Keros Therapeutics, Inc. KROS 612.72 8.00 -27.67 -28.85 -285.35
Oyster Point Pharma, Inc. OYST 548.10 None 5.51 -9.53 None
Mirum Pharmaceuticals, Inc. MIRM 486.50 None 3.16 -7.18 None
Fulcrum Therapeutics, Inc. FULC 476.10 1.00 8.02 -6.90 None
Biospecifics Technologies Corp. BSTC 462.28 40.00 3.75 19.77 61.80
SIGA Technologies, Inc. SIGA 460.84 19.00 5.16 -23.42 -94.00
89bio, Inc. ETNB 457.80 None 5.65 -7.09 None
Satsuma Pharmaceuticals, Inc. STSA 441.32 None 4.34 -12.13 None
Imara, Inc. IMRA 438.60 None 4.24 -12.46 None
DURECT Corp. DRRX 395.25 28.00 30.36 -16.35 -82.94
Relmada Therapeutics, Inc. RLMD 394.02 0.00 5.88 -32.92 -877.66
Kala Pharmaceuticals, Inc. KALA 383.04 6.00 4.19 -4.17 None
Crinetics Pharmaceuticals, Inc. CRNX 382.56 1.00 4.83 -6.56 -447.78
TCR2 Therapeutics, Inc. TCRR 368.64 None 2.52 -36.57 None
Ocular Therapeutix, Inc. OCUL 357.12 6.00 -43.76 -3.90 None
Ovid Therapeutics, Inc. OVID 344.25 None 8.14 -5.28 None
Osmotica Pharmaceuticals Plc OSMT 343.44 232.00 2.61 -1.25 -115.44
Aeglea Biotherapeutics, Inc. AGLE 303.27 4.00 9.57 -3.78 -523.27
Urovant Sciences Ltd. UROV 295.80 None -5.24 -2.05 None
IDEAYA Biosciences, Inc. IDYA 270.40 None 4.11 -6.20 None
Spero Therapeutics, Inc. SPRO 268.28 12.00 3.53 -3.30 -656.72
AMAG Pharmaceuticals, Inc. AMAG 268.26 321.00 1.02 -0.72 -115.05
HOOKIPA Pharma, Inc. HOOK 267.80 13.00 2.42 -5.92 -333.02
Verrica Pharmaceuticals, Inc. VRCA 257.50 None 4.70 -8.44 None
Lannett Co., Inc. LCI 242.82 542.00 0.83 -7.99 -5.77
Gritstone Oncology, Inc. GRTS 226.44 4.00 2.03 -2.17 None
KalVista Pharmaceuticals, Inc. KALV 211.68 12.00 2.34 -6.53 -263.38
Kaleido Biosciences, Inc. KLDO 207.90 None 7.37 -2.84 None
Veru, Inc. VERU 207.35 39.00 6.93 -21.27 -25.53
Sutro Biopharma, Inc. STRO 194.81 41.00 3.70 -3.20 -148.06
Protara Therapeutics, Inc. TARA 191.34 None 2.88 -12.41 None
Galera Therapeutics, Inc. GRTX 187.25 None 3.50 -2.85 None
LogicBio Therapeutics, Inc. LOGC 175.03 1.00 5.28 -4.11 None
Liquidia Technologies, Inc. LQDA 166.10 8.00 13.02 -3.37 -602.17
scPharmaceuticals, Inc. SCPH 156.37 119.00 4.00 -4.99 -27.05
Avenue Therapeutics, Inc. ATXI 156.00 532.00 28.68 -10.71 26.69
Cyclerion Therapeutics, Inc. CYCN 153.49 6.00 1.93 -1.48 None
Corvus Pharmaceuticals, Inc. CRVS 147.45 None 2.36 -3.12 None
Tyme Technologies, Inc. TYME 144.90 None 8.40 -6.63 None
Lyra Therapeutics, Inc. LYRA 144.84 1.00 -1.23 -8.68 -491.16
Evelo Biosciences, Inc. EVLO 144.00 None 5.29 -1.64 None
PhaseBio Pharmaceuticals, Inc. PHAS 134.85 2.00 2.50 -2.82 None
Harrow Health, Inc. HROW 133.38 51.00 8.55 -5.40 -47.54
Aquestive Therapeutics, Inc. AQST 128.24 49.00 -7.39 -1.82 -139.64
Mustang Bio, Inc. MBIO 125.60 None 2.93 -2.55 None
TFF Pharmaceuticals, Inc. TFFP 117.80 None 4.56 -3.04 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
NeuBase Therapeutics, Inc. NBSE 117.04 None 49.18 -2.62 None
Ayala Pharmaceuticals, Inc. AYLA 115.41 3.00 -2.72 -5.59 -679.19
Evolus, Inc. EOLS 100.50 45.00 1.80 -0.99 -217.51
Trevi Therapeutics, Inc. TRVI 98.82 None 2.10 -3.37 None
Eton Pharmaceuticals, Inc. ETON 94.32 1.00 10.27 -4.72 None
Milestone Pharmaceuticals, Inc. MIST 93.86 None 0.93 -1.51 None
EyePoint Pharmaceuticals, Inc. EYPT 78.49 26.00 5.54 -1.60 -196.30
Checkpoint Therapeutics, Inc. CKPT 76.80 2.00 6.62 -3.31 -949.53
Clearside Biomedical, Inc. CLSD 76.67 6.00 9.84 -4.35 -293.61
Xeris Pharmaceuticals, Inc. XERS 74.48 4.00 3.69 -0.57 None
Baudax Bio, Inc. BXRX 65.70 None -1.79 -0.94 None
Navidea Biopharmaceuticals, Inc. NAVB 64.60 1.00 -47.50 -5.85 -65.13
BiomX, Inc. PHGE 60.06 None 1.58 -1.40 None
Genprex, Inc. GNPX 59.60 None 5.06 -4.36 None
Assertio Therapeutics, Inc. ASRT 57.60 192.00 1.00 -0.35 -83.99
Aridis Pharmaceuticals, Inc. ARDS 55.44 1.00 -22.81 -1.90 -851.00
Aerpio Pharmaceuticals, Inc. ARPO 53.71 20.00 1.62 -2.85 -51.58
Menlo Therapeutics, Inc. MNLO 49.30 2.00 4.15 -0.53 -483.51
Edesa Biotech, Inc. EDSA 45.36 0.00 6.46 -0.48 -395.23
Eyenovia, Inc. EYEN 44.20 None 4.46 -2.16 None
Annovis Bio, Inc. ANVS 42.49 None 3.89 -33.72 None
Moleculin Biotech, Inc. MBRX 40.94 None 3.56 -4.45 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Citius Pharmaceuticals, Inc. CTXR 35.37 None 2.62 -2.05 None
AgeX Therapeutics, Inc. AGE 33.82 2.00 -44.50 -2.78 -658.11
Allena Pharmaceuticals, Inc. ALNA 33.81 None 4.45 -0.78 None
Mannatech, Inc. MTEX 33.70 156.00 1.42 7.59 3.45
Oncternal Therapeutics, Inc. ONCT 33.67 3.00 4.32 -1.34 -225.89
Acer Therapeutics, Inc. ACER 32.20 3.00 2.35 -1.23 -274.69
CNS Pharmaceuticals, Inc. CNSP 31.20 None 5.42 -5.74 None
Aileron Therapeutics, Inc. ALRN 30.80 None 4.23 -1.16 None
Adamis Pharmaceuticals Corp. ADMP 30.16 22.00 1.16 -1.02 -140.33
Hoth Therapeutics, Inc. HOTH 25.40 None 7.06 -2.82 None
Millendo Therapeutics, Inc. MLND 25.20 0.00 0.59 -0.54 None
Spring Bank Pharmaceuticals, Inc. SBPH 24.77 0.00 0.94 -0.95 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.81 1.00 8.25 -1.13 None
ProPhase Labs, Inc. PRPH 16.92 9.00 1.53 -5.64 -31.15
Adial Pharmaceuticals, Inc. ADIL 15.00 None 3.66 -1.97 None
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.33 5.00 -3.29 -0.45 -602.34
PDS Biotechnology Corp. PDSB 13.30 None 1.47 -0.52 None
Titan Pharmaceuticals, Inc. TTNP 12.07 4.00 5.03 -0.67 -437.91
Novus Therapeutics, Inc. NVUS 7.44 None 0.64 -0.35 None
Brickell Biotech, Inc. BBI 4.68 5.00 1.53 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Repligen Announces Agreement to Acquire Engineered Molding Technology

9d ago, source: YAHOO!

Repligen Corporation (RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into an agreement to acquire Albany, New York based Engineered ...

Here's Why Repligen Rose 33.6% in the First Half of 2020

23h ago, source: The Motley Fool

Shares of Repligen (NASDAQ:RGEN) rose nearly 34% in the first half of 2020, according to data provided by S&P Global Market Intelligence. That easily bested the 4% decline of the S&P 500 in what has ...

Canopy Growth Corporation (CGC): Are Hedge Funds Right About This Stock?

1d ago, source: YAHOO!

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they ...

Repligen Co. to Post Q1 2021 Earnings of $0.29 Per Share, William Blair Forecasts (NASDAQ:RGEN)

6d ago, source: modernreaders.com

Investment analysts at William Blair boosted their Q1 2021 earnings per share estimates for shares of Repligen in a report released on Monday, June 29th. William Blair analyst J. Kreger now expects ...

Repligen Announces Agreement to Acquire Engineered Molding Technology

10d ago, source: Benzinga.com

WALTHAM, Mass., June 29, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered ...

Repligen Announces Agreement to Acquire Engineered Molding Technology

10d ago, source: Stockhouse

WALTHAM, Mass., June 29, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into ...

BRIEF-Repligen Announces Agreement To Acquire Engineered Molding Technology

10d ago, source: Reuters

REPLIGEN ANNOUNCES AGREEMENT TO ACQUIRE ENGINEERED MOLDING TECHNOLOGY * REPLIGEN CORP - ENTERED INTO AN AGREEMENT TO ACQUIRE ALBANY, NEW YORK ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.